Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24524N0789
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Belle Isle, FL 32809, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $12.6K, was awarded on August 1, 2024, to Otsuka America Pharmaceutical Inc. for the supply of Jynarque (tolvaptan) 90mg/30mg tablets to the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5). The award is structured as a firm fixed-price delivery order with no set-aside designation, utilizing the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) as its parent master contract. Performance is scheduled for completion by August 6, 2024, at the VA facility located in Belle Isle, Florida.
This delivery order represents a specific task executed under Otsuka America Pharmaceutical Inc.'s larger $83.3 million Blanket Purchase Agreement with the National Acquisition Center for Jynarque supply across multiple VA Integrated Service Networks. Jynarque is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring targeted treatment within the VA's veteran population. The contractor maintains substantial federal supply schedule contracts exceeding $396 million for pharmaceutical and hematology-related products, positioning it as a primary supplier of specialized medications to the Veterans Health Administration across numerous regional networks nationwide.
Quick answers
Who was awarded contract 36C24524N0789?
36C24524N0789 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 1, 2024.
How much is contract 36C24524N0789 worth?
The government has obligated $12,560 on 36C24524N0789.
Is contract 36C24524N0789 an order under another contract?
Yes. 36C24524N0789 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0789 competed?
The extent of competition for 36C24524N0789 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award